MedTrace Logo

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

NCT00426296 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2007-11-01

No results posted yet for this study

Summary

SHARE: Simple HAART with Abacavir, Reyataz, and Epivir

Conditions

  • HIV Infections
  • Lipodystrophy

Interventions

DRUG

atazanavir (Reyataz)

DRUG

ritonavir (Norvir)

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Clinical Alliance for Research & Education - Infectious Diseases, LLC.

    lead OTHER

Principal Investigators

  • Richard A Elion, MD · Whitman-Walker Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00426296 on ClinicalTrials.gov